2020
DOI: 10.1155/2020/1719279
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Altered Levels of Pro- and Anti-Inflammatory Mediators on Locations of In-Stent Reocclusions in Elderly Patients

Abstract: Imbalances of proatherogenic inflammatory and antiatherogenic inflammatory mediators were involved in the pathogenesis of atherosclerosis. This study sought to investigate the effects of proatherogenic inflammatory and antiatherogenic inflammatory mediators on the proximal, middle, and distal coronary artery reocclusions in elderly patients after coronary stent implantations. We measured the expression levels of proatherogenic inflammatory/antiatherogenic inflammatory cytokines. This included interleukin-1 β (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 39 publications
0
0
0
1
Order By: Relevance
“…Moreover, the proximal and distal atherosclerotic lesions presented different histological compositions [9] due to diverse pathophysiological processes involved in the development and progression of the plaques. In Li et al's study [20] the differences between proatherogenic inflammatory and antiatherogenic inflammatory markers, including interleukins (IL) (IL-1β, IL-6, IL-8, IL-10, IL-17, IL-13, IL-37), TNF-α, and hs-CRP were related to different occlusion risk after percutaneous coronary procedures in the proximal, medial, or distal segments of the vessels.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the proximal and distal atherosclerotic lesions presented different histological compositions [9] due to diverse pathophysiological processes involved in the development and progression of the plaques. In Li et al's study [20] the differences between proatherogenic inflammatory and antiatherogenic inflammatory markers, including interleukins (IL) (IL-1β, IL-6, IL-8, IL-10, IL-17, IL-13, IL-37), TNF-α, and hs-CRP were related to different occlusion risk after percutaneous coronary procedures in the proximal, medial, or distal segments of the vessels.…”
Section: Discussionmentioning
confidence: 99%
“…Eles pertencem a uma classe de medicamentos mais difundidas em todo mundo, sendo bastante utilizados em casos de dor aguda ou crônica devido a processos inflamatórios. Os AINEs são comumente utilizados por apresentarem propriedade analgésica, antitérmica, anti-inflamatória e antitrombótica, atuam através da inibição de prostaglandinas (PGs) (Quadro 1), que são substâncias endógenas intermediárias do processo inflamatório, pela inativação das isoenzimas cicloxigenases constitutiva (COX1) e indutiva (COX-2) (MOREIRA et al, 2017;LI et al, 2020). Embora garantir o acesso gratuito a medicamentos à população carente seja parte importante da assistência à saúde, integrar a assistência farmacêutica e médica à atenção básica é uma estratégia fundamental para garantir o uso racional de medicamentos e a redução do desperdício farmacêutico.…”
Section: Classificação Dos Ainesunclassified